Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Series B1 Preferred Stock
Previously Reported
Preferred Stock
Preferred Stock
Previously Reported
Common Stock
Common Stock
Series B1 Preferred Stock
Common Stock
Previously Reported
Additional Paid-In Capital
Additional Paid-In Capital
Series B1 Preferred Stock
Additional Paid-In Capital
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported
Beginning Balance (in shares) at Dec. 31, 2020       0 [1] 22,579,695 32,184,263 [1]   16,211,567              
Beginning Balance at Dec. 31, 2020 $ (1,847) [1]   $ (1,847)   $ 2 $ 3 [1]   $ 2 $ 112,994 [1]   $ 112,993 $ (114,567) [1] $ (114,567) $ (277) [1] $ (277)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)           35,895                  
Issuance of Legacy Shapeways common stock upon exercise of stock options 16               16            
Stock-based compensation expense 174               174            
Net (loss) income 1,708                     1,708      
Foreign currency translation adjustment (9)                         (9)  
Ending Balance (in shares) at Mar. 31, 2021       0   32,220,158                  
Ending Balance at Mar. 31, 2021 42     $ 0   $ 3     113,184     (112,859)   (286)  
Beginning Balance (in shares) at Dec. 31, 2020       0 [1] 22,579,695 32,184,263 [1]   16,211,567              
Beginning Balance at Dec. 31, 2020 (1,847) [1]   $ (1,847)   $ 2 $ 3 [1]   $ 2 112,994 [1]   $ 112,993 (114,567) [1] $ (114,567) (277) [1] $ (277)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net (loss) income 1,573                            
Foreign currency translation adjustment (17)                            
Ending Balance (in shares) at Jun. 30, 2021       0   32,302,841                  
Ending Balance at Jun. 30, 2021 185     $ 0   $ 3     113,470     (112,994)   (294)  
Beginning Balance (in shares) at Mar. 31, 2021       0   32,220,158                  
Beginning Balance at Mar. 31, 2021 42     $ 0   $ 3     113,184     (112,859)   (286)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares)           63,506                  
Issuance of Legacy Shapeways common stock upon exercise of stock options 55               55            
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (shares)             19,177                
Issuance of Legacy Shapeways convertible Series B-1 preferred stock resulting from exercise of warrants   $ 60               $ 60          
Stock-based compensation expense 171               171            
Net (loss) income (135)                     (135)      
Foreign currency translation adjustment (8)                         (8)  
Ending Balance (in shares) at Jun. 30, 2021       0   32,302,841                  
Ending Balance at Jun. 30, 2021 185     $ 0   $ 3     113,470     (112,994)   (294)  
Beginning Balance (in shares) at Dec. 31, 2021       0   48,627,739                  
Beginning Balance at Dec. 31, 2021 $ 85,004     $ 0   $ 5     198,179     (112,811)   (369)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) 217,967         217,967                  
Issuance of Legacy Shapeways common stock upon exercise of stock options $ 99               99            
Stock-based compensation expense 312               312            
Net (loss) income (4,037)                     (4,037)      
Transfer of Private Warrants to Public Warrants 382               382            
Foreign currency translation adjustment (52)                         (52)  
Ending Balance (in shares) at Mar. 31, 2022       0   48,845,706                  
Ending Balance at Mar. 31, 2022 81,708     $ 0   $ 5     198,972     (116,848)   (421)  
Beginning Balance (in shares) at Dec. 31, 2021       0   48,627,739                  
Beginning Balance at Dec. 31, 2021 85,004     $ 0   $ 5     198,179     (112,811)   (369)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net (loss) income (8,711)                            
Foreign currency translation adjustment (226)                            
Ending Balance (in shares) at Jun. 30, 2022       0   49,213,438                  
Ending Balance at Jun. 30, 2022 77,794     $ 0   $ 5     199,906     (121,522)   (595)  
Beginning Balance (in shares) at Mar. 31, 2022       0   48,845,706                  
Beginning Balance at Mar. 31, 2022 $ 81,708     $ 0   $ 5     198,972     (116,848)   (421)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of Legacy Shapeways common stock upon exercise of stock options (Shares) 367,732         367,732                  
Issuance of Legacy Shapeways common stock upon exercise of stock options $ 189               189            
Stock-based compensation expense 457               457            
Net (loss) income (4,674)                     (4,674)      
Transfer of Private Warrants to Public Warrants 288               288            
Foreign currency translation adjustment (174)                         (174)  
Ending Balance (in shares) at Jun. 30, 2022       0   49,213,438                  
Ending Balance at Jun. 30, 2022 $ 77,794     $ 0   $ 5     $ 199,906     $ (121,522)   $ (595)  
[1] Retroactively restated for the reverse recapitalization as described in Notes 1 and 2.